We proudly present our Confirmed Speakers
Plenary Speakers
Alzheimer Treatment:
Past, present and future
Prof. Ricardo F. Allegri
Professor of Neurology
School of Medicine, Universidad de Buenos Aires
Head of Department of Cognitive Neurology, Neuropsychology and Neuropsychiatry, Instituto de Investigaciones Neurológicas Fleni
Buenos Aires, Argentina
Brain Dimensions of Depression:
From Biomarkers to Home-Based Neuromodulation
Prof. Cynthia Fu
Professor of Affective Neuroscience
Director, Affective Clinical Neuroscience Unit, Department of Psychology and Human Development, University of East London
London, United Kingdom
The Bipolar Action Network: A Collaborative Organization to Improve Outcomes
Prof. Andrew A. Nierenberg
Professor of Psychiatry
Harvard Medical School
Director of Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital
Boston, United States
Development and application of biomarkers for Alzheimer's disease
Dr. Pedro Rosa-Neto
Professor in the Department of Neurology at the UT Southwestern Medical Center
Director of the Translational Neuroimaging Laboratory and Acting Director of the NT-ADRC
Dallas, United States
Debate Speakers
Cannabis use in adolescence negatively impacts emerging adults' neurodevelopmental and cognitive abilities’
Proponent:
Prof. Robin Murray
Professor of Psychiatric Research
Institute of Psychiatry, Psychology and Neuroscience
King’s College
London, United Kingdom
Opponent:
Dr. Debasish Basu
Former Professor and Head
Department of Psychiatry,
Postgraduate Institute of Medical Education & Research (PGIMER)
Chandigarh, India
Are GLP-1 receptor agonists the new frontier in the treatment of psychiatric disorders?
Proponent:
Prof. Dan Siskind
Professor
University of Queensland,
Faculty of Health,
Medicine and Behavioural Science
Brisbane, Australia
Opponent:
Prof. Andreas Reif
Chair
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy,
University Medical Centre Frankfurt
Frankfurt, Germany
Immuno-metabolic depression: Is it prime time to adopt immuno-metabolic modulating pharmacological and lifestyle interventions?
Proponent:
Prof. Jane A. Foster
Professor
Center for Depression Research and Clinical Care,
Division of General Psychiatry,
UT Southwestern Medical Center
Dallas, United States
Opponent:
Prof Gin S. Malhi
Professor
School of Psychiatry,
University of New South Wales
Sydney, Australia
State-of-the-Art Session Speakers
Advances in Psychosis:
Real Advances and Chimeras Over the Past Half-Century
Prof. Robin Murray
Professor of Psychiatric Research
Institute of Psychiatry, Psychology and Neuroscience,
King’s College
London, United Kingdom
Cognitive neuroscience of antidepressant action - what’s new and why does it matter?
Prof. Catherine Harmer
Professor of Cognitive Neuroscience
Associate Head of Department People & Culture,
University of Oxford
Warneford Hospital
Oxford, United Kingdom
Medication strategies for managing difficult-to-treat depression in young people: Absence of evidence or evidence of absence?
Prof. Christopher Davey
Chair and Head
Department of Psychiatry, University of Melbourne
Consultant Psychiatrist, Royal Melbourne Hospital
Melbourne, Australia
Presidential Symposium Speakers
Beyond DSM-5: What Comes Next—and Why It Matters’ or ‘The Future of Diagnosis: Inside the Next DSM
Prof. Anissa Abi-Dargham
Chair
Psychiatry and Behavioral Health
Stony Brook Medicine
New York, United States
Nitin Gogtay, MD
VP
Division of Research
Deputy Medical Director
American Psychiatric Association
Bethesda, United States
Drug Pipeline Symposium Speakers
Further confirmed speakers will be announced shortly.